IGF-1

Bioregulator / organ-specific signaling

Organ/tissue functional restoration and durable adaptive support

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide bioregulator
Primary mechanism: Tissue-specific peptide signaling; gene-expression/protein synthesis modulation
Primary market use: Bioregulator / organ-specific signaling

Pharmacology

Oral bioavailability: Route-dependent / verify
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: SubQ; Injectable; route-dependent
Evidence level: Vendor/source-list + secondary signal
Clinical status: Research/reference; verify status
Value-for-money score: 9 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Listed as catalog fact sheet or protocol product | Listed as peptide or bioregulator chapter entry